PROVECTUS BIOPHARMACEUTICALS, INC. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, conversion of units for the quarter ending 2024-09-30 was $2.13M.
- PROVECTUS BIOPHARMACEUTICALS, INC. stock issued during period, value, conversion of units for fiscal 2024 was $2.13M.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2024-12-31 | $2.13M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $2.13M 10-Q · filed 2025-11-13 |